Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cytotherapy
|
September 24, 2019
More acute lymphoid leukemia than acute myeloid leukemia blasts are killed by rabbit antithymocyte globulin
Rosy Dabas, Poonam-Dharmani Khan, Monica Modi, et al.
The Oncologist
|
October 6, 2025
Management of Canadian patients with refractory or relapsed diffuse large B-cell lymphoma in the real world: a subanalysis of the RE-MIND2 study
Anthea Peters, Grzegorz S Nowakowski, Rosy Dabas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 21, 2018
Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the Levels
Kareem Jamani, Rosy Dabas, Shahbal B Kangarloo, et al.
Bone Marrow Transplantation
|
August 16, 2018
Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells
Rosy Dabas, Poonam Dharmani-Khan, Monica Modi, et al.
Transplantation and Cellular Therapy
|
January 14, 2026
Population pharmacokinetics and optimal exposure of anti-thymocyte globulin in myeloablative hematopoietic cell transplantation
Hamid Ghazal, Sofia Leuchter, Riley Ngo, et al.
Transplantation and Cellular Therapy
|
October 4, 2021
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation
Megan Kinzel, Michelle Dowhan, Amit Kalra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 19, 2016
Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts
Rosy Dabas, Rachelle Lee, Maria Theresa Servito, et al.
Cytotherapy
|
January 1, 2020
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era
Christopher Evernden, Michelle Dowhan, Rosy Dabas, et al.
Blood Advances
|
May 3, 2019
Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin
Rosy Dabas, Kareem Jamani, Shahbal B Kangarloo, et al.
Cytotherapy
|
September 3, 2022
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease
Rutvij A Khanolkar, Gaurav Tripathi, Poonam Dharmani-Khan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cytotherapy
|
September 24, 2019
More acute lymphoid leukemia than acute myeloid leukemia blasts are killed by rabbit antithymocyte globulin
Rosy Dabas, Poonam-Dharmani Khan, Monica Modi, et al.
The Oncologist
|
October 6, 2025
Management of Canadian patients with refractory or relapsed diffuse large B-cell lymphoma in the real world: a subanalysis of the RE-MIND2 study
Anthea Peters, Grzegorz S Nowakowski, Rosy Dabas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 21, 2018
Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the Levels
Kareem Jamani, Rosy Dabas, Shahbal B Kangarloo, et al.
Bone Marrow Transplantation
|
August 16, 2018
Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells
Rosy Dabas, Poonam Dharmani-Khan, Monica Modi, et al.
Transplantation and Cellular Therapy
|
January 14, 2026
Population pharmacokinetics and optimal exposure of anti-thymocyte globulin in myeloablative hematopoietic cell transplantation
Hamid Ghazal, Sofia Leuchter, Riley Ngo, et al.
Transplantation and Cellular Therapy
|
October 4, 2021
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation
Megan Kinzel, Michelle Dowhan, Amit Kalra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 19, 2016
Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts
Rosy Dabas, Rachelle Lee, Maria Theresa Servito, et al.
Cytotherapy
|
January 1, 2020
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era
Christopher Evernden, Michelle Dowhan, Rosy Dabas, et al.
Blood Advances
|
May 3, 2019
Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin
Rosy Dabas, Kareem Jamani, Shahbal B Kangarloo, et al.
Cytotherapy
|
September 3, 2022
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease
Rutvij A Khanolkar, Gaurav Tripathi, Poonam Dharmani-Khan, et al.
Page
of 2